Dr. Lal PathLabs Limited(IN:LALPATHLAB)
₹2,029.30+18.40 (+0.92%)
IN:LALPATHLAB
Dr. Lal PathLabs Limited financials statements
₹2,029.30
At close:+18.40 (+0.92%)
Want to see IN:LALPATHLAB full AI Analyst Report?
Dr. Lal PathLabs Limited (LALPATHLAB) Ratios
2 Followers
Dr. Lal PathLabs Limited Ratios
IN:LALPATHLAB's free cash flow for Q1 2027 was ₹0.00. For the 2027 fiscal year, IN:LALPATHLAB's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.48 | 3.39 | 2.42 | 2.07 | 1.75 |
| Quick Ratio | 3.38 | 3.30 | 2.34 | 2.00 | 1.65 |
| Cash Ratio | 0.54 | 0.73 | 0.78 | 0.56 | 0.76 |
| Solvency Ratio | 1.10 | 1.23 | 0.80 | 0.50 | 0.51 |
| Operating Cash Flow Ratio | 1.56 | 1.41 | 1.15 | 0.97 | 0.89 |
| Short-Term Operating Cash Flow Coverage | 13.10 | 10.38 | 6.42 | 2.97 | 2.50 |
| Net Current Asset Value | ₹ 9.62B | ₹ 8.53B | ₹ 5.56B | ₹ 2.87B | ₹ 654.68M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.06 | 0.10 | 0.18 | 0.23 |
| Debt-to-Equity Ratio | 0.08 | 0.07 | 0.13 | 0.25 | 0.35 |
| Debt-to-Capital Ratio | 0.07 | 0.07 | 0.12 | 0.20 | 0.26 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.05 | 0.10 |
| Financial Leverage Ratio | 1.25 | 1.25 | 1.33 | 1.43 | 1.56 |
| Debt Service Coverage Ratio | 9.09 | 8.51 | 3.76 | 1.77 | 1.89 |
| Interest Coverage Ratio | 27.22 | 25.13 | 29.45 | 20.44 | 27.17 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 |
| Interest Debt Per Share | 13.29 | 10.77 | 16.60 | 27.50 | 33.91 |
| Net Debt to EBITDA | -0.05 | -0.17 | -0.20 | 0.35 | 0.30 |
| Profitability Margins | |||||
| Gross Profit Margin | 42.01% | 66.56% | 57.44% | 55.78% | 55.94% |
| EBIT Margin | 25.04% | 26.29% | 21.02% | 16.87% | 21.78% |
| EBITDA Margin | 30.90% | 32.04% | 25.48% | 21.88% | 24.86% |
| Operating Profit Margin | 22.47% | 22.77% | 38.83% | 38.04% | 39.27% |
| Pretax Profit Margin | 24.22% | 25.39% | 22.70% | 17.05% | 22.75% |
| Net Profit Margin | 18.27% | 19.79% | 16.07% | 11.84% | 16.52% |
| Continuous Operations Profit Margin | 18.45% | 20.00% | 16.27% | 11.95% | 16.78% |
| Net Income Per EBT | 75.44% | 77.97% | 70.78% | 69.47% | 72.60% |
| EBT Per EBIT | 107.80% | 111.48% | 58.47% | 44.82% | 57.95% |
| Return on Assets (ROA) | 16.05% | 17.93% | 14.57% | 10.01% | 14.65% |
| Return on Equity (ROE) | 20.13% | 22.42% | 19.34% | 14.33% | 22.87% |
| Return on Capital Employed (ROCE) | 23.03% | 24.22% | 43.43% | 40.05% | 44.23% |
| Return on Invested Capital (ROIC) | 16.88% | 18.22% | 29.03% | 25.35% | 29.06% |
| Return on Tangible Assets | 20.99% | 25.40% | 22.31% | 16.14% | 24.76% |
| Earnings Yield | 2.30% | 2.43% | 1.88% | 1.57% | 1.59% |
| Efficiency Ratios | |||||
| Receivables Turnover | 18.70 | 19.88 | 20.21 | 21.51 | 19.62 |
| Payables Turnover | 8.87 | 4.14 | 5.08 | 5.71 | 6.24 |
| Inventory Turnover | 36.49 | 22.80 | 25.40 | 26.39 | 17.51 |
| Fixed Asset Turnover | 5.65 | 7.18 | 6.42 | 4.99 | 4.69 |
| Asset Turnover | 0.88 | 0.91 | 0.91 | 0.85 | 0.89 |
| Working Capital Turnover Ratio | 2.66 | 3.03 | 3.82 | 4.59 | 3.35 |
| Cash Conversion Cycle | -11.63 | -53.78 | -39.44 | -33.08 | -19.03 |
| Days of Sales Outstanding | 19.51 | 18.36 | 18.06 | 16.97 | 18.60 |
| Days of Inventory Outstanding | 10.00 | 16.01 | 14.37 | 13.83 | 20.85 |
| Days of Payables Outstanding | 41.15 | 88.15 | 71.86 | 63.88 | 58.49 |
| Operating Cycle | 29.52 | 34.37 | 32.43 | 30.80 | 39.45 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 42.05 | 34.09 | 32.16 | 27.43 | 26.92 |
| Free Cash Flow Per Share | 32.05 | 31.44 | 29.09 | 24.75 | -1.78 |
| Dividend Paid and CapEx Coverage Ratio | 1.80 | 2.26 | 2.12 | 3.09 | 0.75 |
| Capital Expenditure Coverage Ratio | 4.20 | 12.84 | 10.46 | 10.22 | 0.94 |
| Operating Cash Flow Coverage Ratio | 3.53 | 3.61 | 2.17 | 1.09 | 0.84 |
| Operating Cash Flow to Sales Ratio | 0.25 | 0.23 | 0.24 | 0.23 | 0.21 |
| Free Cash Flow Yield | 2.44% | 2.62% | 2.54% | 2.71% | -0.14% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 43.39 | 41.03 | 53.24 | 63.61 | 62.80 |
| Price-to-Sales (P/S) Ratio | 7.93 | 8.13 | 8.55 | 7.53 | 10.37 |
| Price-to-Book (P/B) Ratio | 8.73 | 9.21 | 10.30 | 9.12 | 14.36 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 40.94 | 38.16 | 39.34 | 36.93 | -735.38 |
| Price-to-Operating Cash Flow Ratio | 31.20 | 35.19 | 35.58 | 33.32 | 48.48 |
| Price-to-Earnings Growth (PEG) Ratio | 12.69 | 1.15 | 1.08 | -2.06 | 3.48 |
| Enterprise Value Multiple | 25.61 | 25.21 | 33.37 | 34.79 | 42.04 |
| Enterprise Value | 218.59B | 198.79B | 189.31B | 153.48B | 218.11B |
| EV to EBITDA | 25.61 | 25.21 | 33.37 | 34.79 | 42.04 |
| EV to Sales | 7.91 | 8.08 | 8.50 | 7.61 | 10.45 |
| EV to Free Cash Flow | 40.86 | 37.90 | 39.10 | 37.31 | -740.62 |
| EV to Operating Cash Flow | 31.14 | 34.95 | 35.36 | 33.66 | 48.83 |
| Tangible Book Value Per Share | 107.86 | 84.36 | 62.05 | 47.74 | 35.15 |
| Shareholders’ Equity Per Share | 150.25 | 130.24 | 111.09 | 100.25 | 90.90 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.21 | 0.28 | 0.30 | 0.26 |
| Revenue Per Share | 165.51 | 147.53 | 133.76 | 121.34 | 125.82 |
| Net Income Per Share | 30.24 | 29.20 | 21.49 | 14.37 | 20.79 |
| Tax Burden | 0.75 | 0.78 | 0.71 | 0.69 | 0.73 |
| Interest Burden | 0.97 | 0.97 | 1.08 | 1.01 | 1.04 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.20 | 0.18 | 0.14 | 0.14 | 0.14 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 |
| Income Quality | 1.39 | 1.17 | 1.50 | 1.89 | 1.28 |
Currency in INR
